Intuitive Surgical beats quarterly estimates on demand for surgical robots

January 22, 2026 4:45 PM EST

Jan 22 (Reuters) - Intuitive ⁠Surgical on Thursday ⁠beat ‍Wall Street estimates for fourth-quarter profit and revenue on growing demand for its surgical robots ‍used in minimally invasive procedures.

Shares of the Sunnyvale, ​California-based company rose 3.3% in after-hours trading.

The medical device maker has ​seen consistent growth as hospitals work through a backlog of deferred procedures and expand access to minimally invasive care.

Intuitive's da Vinci surgical robots ​are widely used for a range of procedures including weight-loss surgeries and treatments for digestive, bladder and ​heart conditions.

The volume of da Vinci procedures globally rose about 18% from a ‌year ago in the reported quarter, the company said.

More than 80% of the instruments and ​accessories for the system are produced at ⁠Intuitive's facility in Mexico. The company also operates in China and other international markets.

Intuitive ‌expects da Vinci-assisted procedures to increase about 13% to 15% worldwide this year, compared with 18% growth in 2025.

It also expects ‌2026 gross profit margin between 67% and 68% of revenue, compared ‌with 67.6% in 2025. This range includes an estimated impact from tariffs of 1.2% of revenue, plus or minus 10 basis points, ‍the company said.

On an adjusted basis, Intuitive earned $2.53 per share for the quarter ended ⁠December 31, beating analysts' estimates of $2.26 per share, according to data compiled by LSEG.

It reported quarterly revenue of $2.87 billion, compared with analysts' estimates of $2.75 billion.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

General News, Reuters